The Peptide AWRK6 Alleviates Lipid Accumulation in Hepatocytes by Inhibiting miR-5100 Targeting G6PC

Non-alcoholic fatty liver disease (NAFLD) is the leading chronic liver disease, with a worldwide prevalence of more than 25%, and there is no approved drug for NAFLD specifically. In our previous study, the synthetic peptide AWRK6 was found to ameliorate NAFLD in mice. However, the mechanisms involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiaxin, Liu, Ying, Wang, Qiuyu, Jin, Lili, Zhang, Dianbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671387/
https://www.ncbi.nlm.nih.gov/pubmed/38003331
http://dx.doi.org/10.3390/ijms242216141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671387/
https://www.ncbi.nlm.nih.gov/pubmed/38003331
http://dx.doi.org/10.3390/ijms242216141

Ejemplares similares